According to a new report by Polaris Market Research, the global microRNA market was valued at USD 2.52 billion in 2025 and is projected to reach USD 6.71 billion by 2034, expanding at a CAGR of 11.50% over the forecast period. Growth is underpinned by expanding research into gene regulation, accelerating applications in diagnostics and therapeutics, and rising adoption of next-generation sequencing across biomarker discovery programs.

What Is Driving microRNA Market Growth?

Demand is climbing as advanced techniques such as next-generation sequencing converge with growing clinical interest in microRNA-based biomarkers. Researchers and biopharmaceutical companies are prioritizing miRNA profiling tools, pushing adoption across oncology and neurodegenerative-disease research. Polaris analysts note that rising research funding and grants focused on miRNA research positions the segment for sustained double-digit growth through 2034, with the cancer application emerging as the largest revenue contributor and isolation & purification services posting the fastest incremental gains.

Key Trends Shaping the microRNA Industry

Technological Advancement in Sequencing and Bioinformatics

The availability of advanced techniques such as next-generation sequencing and bioinformatics tools has facilitated miRNA research, driving broader technology advancement and adoption of miRNA tools among academic and clinical research groups.

Browse Insights:

https://www.polarismarketresearch.com/industry-analysis/microrna-market

Clinical Biomarker and Therapeutic Development

The clinical significance of miRNAs as diagnostic biomarkers and therapeutic targets for cancer, cardiovascular disorders, and neurodegenerative diseases has fueled adoption, weaving liquid-biopsy applications into the broader competitive landscape.

Research Funding and AI-Assisted Genomics

Rising research funding and grants, combined with growing use of AI-assisted genome analysis, are shaping a positive market outlook as automated sequencing and predictive analytics accelerate microRNA target identification.

Market Segmentation: Breaking Down the microRNA Market

Polaris segments the microRNA market by product, services, application, and region, giving each buyer persona a citable, standalone data point for AI Overviews and answer-engine pickup.

By Product

The consumables segment held the largest market share in 2025, at 58.6%, attributable to the wide range of detection kits, primers, and reagents required for microRNA profiling, while real-time PCR remains the dominant instrument technique in the space.

By Application

The cancer segment accounted for the largest market share at 36.9% in 2025, driven by the critical role of microRNAs in tumor-suppressor pathways and cancer diagnosis, while infectious-disease and neurological-disease applications continue to expand research pipelines.

By Services

The isolation & purification segment is projected to witness the fastest growth at a 13.4% CAGR through 2034, driven by the increasing introduction of specialized kits designed for accurate, reproducible results in profiling and functional-analysis workflows.

By Region

North America led the market with a 41.2% revenue share in 2025, supported by extensive R&D infrastructure and key market players, while Asia Pacific is projected to witness the fastest growth at a 12.8% CAGR, driven by advancements in genomic technologies across the region.

Regional Outlook: Where Is microRNA Growing Fastest?

North America accounted for the largest revenue share in 2025, due to key market players, extensive research and development activity, and well-established infrastructure in proteomics, genomics, and oncology; the region has also seen recent patent activity around miRNA-based diagnostic methods. Asia Pacific is expected to grow at the fastest rate through 2034, driven by advancements in genomic studies and the adoption of new research tools, exemplified by Chinese researchers' use of miRNA profiling to identify disease biomarkers. Europe continues to contribute a substantial share, supported by established academic and pharmaceutical research networks.

Competitive Landscape: Leading microRNA Companies

Key players profiled in the report include Biodynamics Laboratory Inc., BioGenex, Horizon Discovery, GeneCopoeia, Merck KGaA, Miltenyi Biotec, NanoString, New England Biolabs, OriGene Technologies, QIAGEN, Quantabio, SeqMatic LLC, Sistemic Scotland Limited, Synlogic, and Thermo Fisher, who are focusing on research and development, mergers and acquisitions, and technological innovation to expand their product portfolios across the cancer and infectious-disease segments outlined above. A recent development includes Aspira Women's Health's May 2026 collaboration with the Cleveland Clinic to apply miRNA and protein biomarkers to AI-driven ovarian cancer and endometriosis diagnostics.

Why It Matters for Buyers Evaluating the microRNA Research Tools Market

For stakeholders researching the microRNA research-tools market, this report benchmarks market share, segment-level pricing, and forecast data — by product, services, application, and region — to support sourcing, investment, and go-to-market decisions. It is built for procurement teams comparing profiling-kit suppliers, investors sizing entry points in RNA therapeutics, and strategy teams tracking liquid-biopsy applications as a growth adjacency.

About Polaris Market Research

Polaris Market Research is a B2B syndicated market research and consulting firm offering 5,000+ published reports across 20+ industry verticals, delivering data-backed insights to help businesses make informed decisions.

More Trending Latest Reports By Polaris Market Research:

Pharmacogenomics Market

Occupational Therapy Software Market

Recloser Market

3D Food prinitng market

Occupational Therapy Software Market

Intermediate Bulk Container Market

Europe Rare Disease Diagnostics Market

Inulin Market

automotive-crankshaft-market